← Leaderboards
Feng Yao
Brigham And Women'S Hospital
$1,809,725
Attributed
$1,809,725
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $508.1K · FY2005–11$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$1,809,725 · 2
By mechanism
R01$1,301,646 · 1
R56$508,079 · 1
Top collaborators
No co-investigators on record.
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Hadine Joffe$12,089,762
- Kenneth H Mayer$64,411,257
- Eric C Johannsen$4,978,414
- Elof Eriksson$3,005,082
- Ingrid T. Katz$3,944,890
Others in their field
Top investigators on “Glycoproteins”
- Dennis R. Burton · Scripps Research Institute$211,788,189
- Joseph G Sodroski · University Of Pennsylvania$47,423,604
- Kartik Chandran · Albert Einstein College Of Medicine$41,665,810
- Erica Ollmann Saphire · Scripps Research Institute$32,718,575
- Robert F Garry · Scripps Research Institute, The$32,430,244
- James E Crowe · Vanderbilt University Medical Center$32,099,289
Research focus
GlycoproteinsVirus ReplicationVector VaccineLaboratory MouseIncidenceInfectionImmuneDominant-Negative MutationEnzyme Linked Immunosorbent AssayHerpesvirus 1, HumanImmunityImmunogenicityCd8b1 GeneCellsDefective VirusesAdultCessation Of LifeBinding ProteinsDna BiosynthesisGenesHerpes Simplex Virus VaccinesHerpesviridae VaccineAntigensEffectiveness
Grant awards (5)
Novel dominant-negative HSV-2 recombinant viral vaccines$508,079
R56 · FY2011 · AI · contact PI
Self-limiting, and Dominant-negative Herpes Simplex Virus Recombinants$313,647
R01 · FY2007 · AI · contact PI
Self-limiting, and Dominant-negative HSV Recombinants$323,586
R01 · FY2006 · AI · contact PI
Self-limiting, and Dominant-negative HSV Recombinants$331,936
R01 · FY2005 · AI
Self-limiting, and Dominant-negative HSV Recombinants$332,477
R01 · FY2004 · AI